MCID: MTR002
MIFTS: 44

Mitral Valve Insufficiency malady

Categories: Cardiovascular diseases

Aliases & Classifications for Mitral Valve Insufficiency

Aliases & Descriptions for Mitral Valve Insufficiency:

Name: Mitral Valve Insufficiency 12 42 14 69
Mitral Regurgitation 12 29 52 14
Congenital Insufficiency of Mitral Valve 12 69
Congenital Mitral Insufficiency 12
Congenital Mitral Regurgitation 12
Mitral Valve Incompetence 12

Classifications:



External Ids:

Disease Ontology 12 DOID:11502
ICD10 33 Q23.3
ICD9CM 35 396.3 746.6
MeSH 42 D008944

Summaries for Mitral Valve Insufficiency

MalaCards based summary : Mitral Valve Insufficiency, also known as mitral regurgitation, is related to mitral regurgitation, conductive deafness, and fusion of cervical vertebrae and of carpal and tarsal bones and macrothrombocytopenia with mitral valve insufficiency. An important gene associated with Mitral Valve Insufficiency is NPPB (Natriuretic Peptide B), and among its related pathways/superpathways are MicroRNAs in cardiomyocyte hypertrophy and Cardiomyocyte Differentiation through BMP Receptors. The drugs Heparin and Dopamine have been mentioned in the context of this disorder. Affiliated tissues include heart and brain, and related phenotype is Decreased shRNA abundance.

Related Diseases for Mitral Valve Insufficiency

Diseases in the Mitral Valve Disease family:

Mitral Valve Insufficiency

Diseases related to Mitral Valve Insufficiency via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 50)
id Related Disease Score Top Affiliating Genes
1 mitral regurgitation, conductive deafness, and fusion of cervical vertebrae and of carpal and tarsal bones 12.2
2 macrothrombocytopenia with mitral valve insufficiency 12.1
3 mitral valve disease 11.4
4 mitral valve prolapse, myxomatous 2 11.2
5 mitral valve prolapse, familial, x-linked 11.0
6 ehlers-danlos syndrome, cardiac valvular form 11.0
7 mitral valve prolapse, myxomatous 3 11.0
8 hypogonadism mitral valve prolapse mental retardation 10.3 ACE NPPA
9 histidine metabolism disease 10.3 NPPA NPPB
10 iris disease 10.2 ACE NPPA
11 myxoid chondrosarcoma 10.2 NPPB SULT1E1
12 pericardium disease 10.2 CRELD1 FBN1 NPPB
13 testicular pure germ cell tumor 10.2 CRELD1 FBN1 NPPB
14 inferolateral myocardial infarct 10.2 ACE NPPA NPPB
15 syringomelia hyperkeratosis 10.2 ACE NPPA NPPB
16 median neuropathy 10.2 ACE FBN1 NPPB
17 eastern equine encephalitis 10.2 ACE NPPA NPPB
18 iida kannari syndrome 10.2 ACE NPPA NPPB
19 macroglossia 10.2 CRELD1 NPPB
20 lymphadenitis 10.2 ACE NPPA NPPB
21 pyelonephritis 10.2 ACE NPPA NPPB
22 adult t-cell leukemia 10.2 ACE NPPA NPPB
23 diffuse pulmonary fibrosis 10.2 ACE SAMHD1
24 critical limb ischemia 10.2 ACE NPPA NPPB
25 eye degenerative disease 10.2 ACE NPPB
26 rapidly progressive glomerulonephritis 10.2 ACE NPPA
27 esophagitis, eosinophilic, 1 10.2 FBN1 PDLIM1
28 adams-oliver syndrome 10.1 ACE NPPA NPPB
29 ceroid lipofuscinosis, neuronal, 8 10.1 CRELD1 FBN1 NPPA NPPB
30 testicular germ cell tumor non-seminomatous 10.1 CRELD1 FBN1 IL4I1
31 cerebral convexity meningioma 10.0 ACE CRELD1 FBN1 NPPA NPPB
32 cleft mitral valve 10.0
33 congenital unguarded mitral orifice 10.0
34 mitral valve agenesis 10.0
35 ceroid lipofuscinosis, neuronal, kufs type, adult onset 10.0 ACE FBN1 NPPA NPPB PDLIM1
36 silent myocardial infarction 10.0 IL4I1 SULT1E1
37 retroperitoneal germ cell neoplasm 9.9 EFS SULT1E1
38 american histoplasmosis 9.9 CEP57 CRELD1 HCK NPPA NPPB SAMHD1
39 tendinitis 9.7
40 hemolytic anemia 9.7
41 aneurysm 9.7
42 myocardial infarction 9.7
43 coronary artery disease 9.7
44 congestive heart failure 9.7
45 artery disease 9.7
46 mitral valve stenosis 9.7
47 pulmonary sequestration 9.7
48 cardiomyopathy 9.7
49 deafness, autosomal recessive 79 9.7 ACE FBN1 HCK IL4I1 NPPB PDLIM1
50 suppurative otitis media 8.1 ACE CEP57 CRELD1 EFS FBN1 HCK

Graphical network of the top 20 diseases related to Mitral Valve Insufficiency:



Diseases related to Mitral Valve Insufficiency

Symptoms & Phenotypes for Mitral Valve Insufficiency

GenomeRNAi Phenotypes related to Mitral Valve Insufficiency according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased shRNA abundance GR00251-A-1 9.74 IPO13 PIK3R2 CEP57 CRELD1 HCK IL4I1
2 Decreased shRNA abundance GR00251-A-2 9.74 IPO13 PIK3R2 CEP57 CRELD1 HCK IL4I1
3 Decreased shRNA abundance GR00297-A 9.74 PIK3R2

Drugs & Therapeutics for Mitral Valve Insufficiency

Drugs for Mitral Valve Insufficiency (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 684)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Heparin Approved, Investigational Phase 4,Phase 2,Phase 3 9005-49-6 772 46507594
2
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-61-6, 62-31-7 681
3
Cocaine Approved, Illicit Phase 4,Phase 1 50-36-2 5760 446220
4
Zinc Approved Phase 4,Phase 3,Phase 2,Phase 1 7440-66-6 32051 23994
5
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 50-78-2 2244
6
Iron Approved Phase 4,Phase 1,Phase 2 7439-89-6 23925
7
Gliclazide Approved Phase 4 21187-98-4 3475
8
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 657-24-9 14219 4091
9
Valproic Acid Approved, Investigational Phase 4,Phase 3,Phase 2 99-66-1 3121
10
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
11
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
12
Amlodipine Approved Phase 4 88150-42-9 2162
13
Metoprolol Approved, Investigational Phase 4,Phase 2,Phase 3 37350-58-6, 51384-51-1 4171
14
Amiodarone Approved, Investigational Phase 4,Phase 3 1951-25-3 2157
15
Warfarin Approved Phase 4,Phase 1 81-81-2 6691 54678486
16
Infliximab Approved Phase 4,Phase 2 170277-31-3
17
Bosentan Approved, Investigational Phase 4 147536-97-8 104865
18
Antipyrine Approved Phase 4,Phase 3,Phase 2,Phase 1 60-80-0 2206
19
Aripiprazole Approved, Investigational Phase 4,Phase 3 129722-12-9 60795
20
Benzocaine Approved Phase 4,Phase 3,Phase 2 1994-09-7, 94-09-7 2337
21
Ranolazine Approved, Investigational Phase 4 142387-99-3, 95635-55-5 56959
22
Menthol Approved Phase 4,Phase 2,Phase 3 2216-51-5 16666
23
Ranibizumab Approved Phase 4 347396-82-1 459903
24
Insulin Glargine Approved Phase 4,Phase 2 160337-95-1
25
Insulin Detemir Approved Phase 4 169148-63-4 5311023
26
Ethanol Approved Phase 4,Phase 2,Phase 3,Phase 1 64-17-5 702
27
Diazepam Approved, Illicit, Vet_approved Phase 4 439-14-5 3016
28
Rosiglitazone Approved, Investigational Phase 4 122320-73-4 77999
29
Pioglitazone Approved, Investigational Phase 4,Phase 2 111025-46-8 4829
30
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3 50-28-2 5757 53477783
31
Loperamide Approved Phase 4 53179-11-6 3955
32
Epinephrine Approved, Vet_approved Phase 4,Phase 3 51-43-4 5816
33
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
34
Benazepril Approved, Investigational Phase 4 86541-75-5 5362124
35
Candesartan Approved Phase 4 139481-59-7 2541
36
Donepezil Approved Phase 4,Phase 3 120014-06-4 3152
37
Galantamine Approved Phase 4 357-70-0 9651 908828, 9651
38
Rivastigmine Approved, Investigational Phase 4 123441-03-2 77991
39
Memantine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 19982-08-2 4054
40
Cilostazol Approved Phase 4 73963-72-1 2754
41
Histamine Approved, Investigational Phase 4,Phase 3,Phase 1 75614-87-8, 51-45-6 774
42
Ticlopidine Approved Phase 4,Phase 3,Phase 1 55142-85-3 5472
43
Hydrocortisone Approved, Vet_approved Phase 4,Phase 2 50-23-7 5754 657311
44
Haloperidol Approved Phase 4,Phase 2 52-86-8 3559
45
Olanzapine Approved, Investigational Phase 4,Phase 3 132539-06-1 4585
46
Clozapine Approved Phase 4 5786-21-0 2818
47
Risperidone Approved, Investigational Phase 4 106266-06-2 5073
48
Methylphenidate Approved, Investigational Phase 4 113-45-1 4158
49
Fluoxetine Approved, Vet_approved Phase 4 54910-89-3 3386
50
Ziprasidone Approved Phase 4,Phase 3 146939-27-7 60854

Interventional clinical trials:

(show top 50) (show all 1193)
id Name Status NCT ID Phase
1 Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery Unknown status NCT01431222 Phase 4
2 Effect of Ranolazine on Valvular Disease in Patients With Pacemakers Unknown status NCT01979965 Phase 4
3 Pilot Study of Lovaza (Omega 3 Fatty Acids) to Improve Cardiac Antioxidant/Anti-inflammatory Profile Before Cardiac Surgery Unknown status NCT01046604 Phase 4
4 Safety Study of Melatonin in Stroke Patients Unknown status NCT01863277 Phase 4
5 Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac Surgery Unknown status NCT01201070 Phase 4
6 Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 Diabetes Unknown status NCT00736515 Phase 4
7 A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke Unknown status NCT02152280 Phase 4
8 Regression of Fatty Heart by Valsartan Therapy Unknown status NCT00745953 Phase 4
9 Ranibizumab in Diabetic Vitrectomy Unknown status NCT01306981 Phase 4
10 Master Study for the Investigation of Safety and Efficacy of the SIELLO Pacemaker Leads Unknown status NCT00943046 Phase 4
11 Arterial Catheter to Monitor Glycemia Unknown status NCT01176279 Phase 4
12 Evaluation of a Family Intervention Program for the Management of Overweight or Obese Children Unknown status NCT01878994 Phase 4
13 Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot Study Unknown status NCT01850277 Phase 4
14 The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis Unknown status NCT02480335 Phase 4
15 Clinical Evaluation of Toric Intraocular Lens Made by Aurolab Unknown status NCT01396616 Phase 4
16 Angiotensin-II Blockade in Mitral Regurgitation Completed NCT00587470 Phase 4
17 A Randomized Clinical Trial of Metoprolol in Participants With Mitral Regurgitation. Completed NCT00166400 Phase 4
18 Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study Completed NCT00352196 Phase 4
19 CG Future® Annuloplasty Ring/Band Clinical Trial Completed NCT01074671 Phase 4
20 The Use of Paravertebral Block for Cardiac Surgery Completed NCT02180893 Phase 4
21 Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease Completed NCT00933608 Phase 4
22 Beating Versus Arrested Heart for Mitral Valve Replacement Completed NCT01641614 Phase 4
23 Effect of Etomidate on Hemodynamics and Adrenocortical Function After Cardiac Surgery Completed NCT00415701 Phase 4
24 The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Anxiety and Insomnia Completed NCT00826111 Phase 4
25 Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke (Japan Alteplase Clinical Trial Ⅱ:J-ACT Ⅱ) Completed NCT00412867 Phase 4
26 Merci Registry - Real World Use of the Merci Retrieval System in Acute Ischemic Stroke Completed NCT00478478 Phase 4
27 Cilostazol in Acute Ischemic Stroke Treatment (CAIST) Completed NCT00272454 Phase 4
28 Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar Disorder Completed NCT00181883 Phase 4
29 COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke Completed NCT00814268 Phase 4
30 Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS Methylphenidate Completed NCT00593112 Phase 4
31 Tongxinluo Capsule in Ischemic Stroke Patients(TISS) Completed NCT01919671 Phase 4
32 Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease Completed NCT00551161 Phase 4
33 Continuous Chest Compressions vs AHA Standard CPR of 30:2 Completed NCT01372748 Phase 4
34 Argatroban for Preventing Occlusion and Restenosis After Extracranial Vertebral Artery Stenting Completed NCT01980316 Phase 4
35 Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Schizophrenia Completed NCT00797927 Phase 4
36 Depakote ER in Bipolar Depression Completed NCT00186186 Phase 4
37 Biomarker Assessment of Glutamatergic Target Engagement Completed NCT02134951 Phase 4
38 Comparison of the Administration of Levosimendan and Placebo in the Preparation of Critical Patients for Heart Surgery Completed NCT01595737 Phase 4
39 Edaravone and Argatroban Stroke Therapy Study for Acute Ischemic Stroke Completed NCT00153946 Phase 4
40 The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder Completed NCT00678574 Phase 4
41 Establishment and Evaluation to the Effects of a Clinical Pathway for Acute Ischemic Stroke Completed NCT00966316 Phase 4
42 Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder Completed NCT00626340 Phase 4
43 Imaging Guided Patient Selection for Interventional Revascularization Therapy Completed NCT00963989 Phase 4
44 Premedication for ERCP With Midazolam or Tramadol Completed NCT02436980 Phase 4
45 Valproic Acid Sodium Salt in Bipolar Disorder Completed NCT00431522 Phase 4
46 Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy Completed NCT01917149 Phase 4
47 Neurobiological Adaptations and Pharmacological Interventions in Cocaine Addiction Completed NCT02626494 Phase 4
48 Minocycline for Bipolar Depression Completed NCT01514422 Phase 4
49 A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac) Completed NCT01449006 Phase 4
50 Hyperbaric Oxygen Therapy as Adjunctive Treatment of Chronic Diabetic Foot Ulcers Completed NCT00953186 Phase 4

Search NIH Clinical Center for Mitral Valve Insufficiency

Cochrane evidence based reviews: mitral valve insufficiency

Genetic Tests for Mitral Valve Insufficiency

Genetic tests related to Mitral Valve Insufficiency:

id Genetic test Affiliating Genes
1 Mitral Regurgitation 29

Anatomical Context for Mitral Valve Insufficiency

MalaCards organs/tissues related to Mitral Valve Insufficiency:

39
Heart, Brain

Publications for Mitral Valve Insufficiency

Articles related to Mitral Valve Insufficiency:

(show all 46)
id Title Authors Year
1
Cardiac remodelling and function with primary mitral valve insufficiency studied by magnetic resonance imaging. ( 26758406 )
2016
2
Surgical Repair of Congenital Left Atrial Aneurysm and Mitral Valve Insufficiency in a Four-Year-Old Child. ( 27956709 )
2016
3
Evaluation of growth differentiation factor 11 (GDF11) levels in dogs with chronic mitral valve insufficiency. ( 26733738 )
2016
4
Occurrence of mitral valve insufficiency in clinically healthy Beagle dogs. ( 26599093 )
2015
5
Review of mitral valve insufficiency: repair or replacement. ( 24672698 )
2014
6
Clinical assessment of systolic myocardial deformations in dogs with chronic mitral valve insufficiency using two-dimensional speckle-tracking echocardiography. ( 23429036 )
2013
7
Comparison of the novel Medtentia double helix mitral annuloplasty system with the Carpentier-Edwards Physio annuloplasty ring: morphological and functional long-term outcome in a mitral valve insufficiency sheep model. ( 23566678 )
2013
8
Surgical reconstruction techniques for mitral valve insufficiency from lesions with restricted leaflet motion in infants and children. ( 22169677 )
2012
9
Evaluation of homocysteine levels in dogs with chronic mitral valve insufficiency. ( 22811561 )
2012
10
High-grade mitral valve insufficiency after fracture of the Mitrofix prosthesis. ( 21982121 )
2011
11
Mitral valve growth after posterior annular stabilization with untreated autologous pericardial strip in children with mitral valve insufficiency. ( 20971267 )
2010
12
Accessory left atrial chordae: an unusual cause of mitral valve insufficiency. ( 19660254 )
2010
13
Severe mitral valve insufficiency after transcatheter atrial septal defect closure with the amplatzer septal occluder: a device-related complication. ( 20078713 )
2009
14
Evaluation of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations in dogs with mitral valve insufficiency. ( 19652480 )
2009
15
Ventricular fibrillation in acute mitral valve insufficiency caused by chordae tendineae rupture: report of a surgically corrected case. ( 19283885 )
2009
16
Diagnosis of acute mitral valve insufficiency using emergency bedside echocardiography. ( 19549012 )
2009
17
De novo 18q deletion with mitral valve insufficiency. ( 18990980 )
2008
18
Mitral valve insufficiency: suspension of the posterior leaflet to the mitral annuloplasty ring. ( 18222224 )
2008
19
Decreased systolic function and inadequate hypertrophy in large and small breed dogs with chronic mitral valve insufficiency. ( 17338151 )
2007
20
Degenerative mitral valve insufficiency long term after heart transplantation: clinical and surgical considerations. ( 17484457 )
2007
21
Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency. ( 17916031 )
2007
22
Mitral valve insufficiency and left ventricular remodeling in identical twins. ( 16733180 )
2006
23
Experimental stenting of the posterior mitral leaflet to correct prolapse in mitral valve insufficiency. ( 16112933 )
2005
24
Echocardiographic estimation of mean left atrial pressure in a canine model of acute mitral valve insufficiency. ( 15515583 )
2004
25
Economic impact of mitral valve plasty versus replacement for mitral valve insufficiency. ( 12813377 )
2003
26
Effects of the ACE inhibitor quinapril on echocardiographic variables in horses with mitral valve insufficiency. ( 15109241 )
2003
27
Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. ( 11568022 )
2001
28
Very long-term results (more than 20 years) of valve repair with carpentier's techniques in nonrheumatic mitral valve insufficiency. ( 11568021 )
2001
29
Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: a histomorphometric study of 130 excised segments. ( 10724505 )
1999
30
Acute traumatic mitral valve insufficiency. ( 10421207 )
1999
31
Giant platelets with abnormal surface glycoproteins: a new familial disorder associated with mitral valve insufficiency. ( 9482416 )
1998
32
Reconstructive surgery in congenital mitral valve insufficiency (Carpentier's techniques): long-term results. ( 9451050 )
1998
33
Pulmonary sequestration presenting as mitral valve insufficiency. ( 9856886 )
1998
34
Effects of mild mitral valve insufficiency, sodium intake, and place of blood sampling on the renin-angiotensin system in dogs. ( 8659339 )
1996
35
Results of mitral valve reconstruction in mitral valve insufficiency. ( 7775539 )
1994
36
Prevalence of mitral valve insufficiency in cavalier King Charles spaniels. ( 1595150 )
1992
37
In vitro balloon dilatation of mitral valve stenosis: the importance of subvalvar involvement as a cause of mitral valve insufficiency. ( 2039673 )
1991
38
Increased mitral valve insufficiency during precordial whoop. ( 3383646 )
1988
39
Changes in myofibrillar content and Mg-ATPase activity in ventricular tissues from patients with heart failure caused by coronary artery disease, cardiomyopathy, or mitral valve insufficiency. ( 2969307 )
1988
40
Mitral valve insufficiency with congestive heart failure in a pukeko. ( 7451347 )
1980
41
Left ventricular angiocardiography in congenital mitral valve insufficiency of the dog. ( 1133066 )
1975
42
EKG of the month. Mitral valve insufficiency. ( 4756262 )
1973
43
Iatrogenic myocardial infarction and mitral valve insufficiency in a llama (Lama glama). ( 5014471 )
1972
44
The effect of acute mitral valve insufficiency on left-heart haemodynamics. ( 5427889 )
1970
45
Treatment of acute mitral valve insufficiency. ( 5269781 )
1970
46
An unusual form of mitral valve insufficiency simulating aortic stenosis. ( 5506636 )
1970

Variations for Mitral Valve Insufficiency

Expression for Mitral Valve Insufficiency

Search GEO for disease gene expression data for Mitral Valve Insufficiency.

Pathways for Mitral Valve Insufficiency

Pathways related to Mitral Valve Insufficiency according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1
Show member pathways
11.53 NPPA NPPB PIK3R2
2 10.3 NPPA NPPB
3 9.88 HCK PIK3R2

GO Terms for Mitral Valve Insufficiency

Biological processes related to Mitral Valve Insufficiency according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cGMP biosynthetic process GO:0006182 9.37 NPPA NPPB
2 regulation of blood vessel size GO:0050880 9.32 NPPA NPPB
3 regulation of vasodilation GO:0042312 9.26 ACE NPPB
4 receptor guanylyl cyclase signaling pathway GO:0007168 9.16 NPPA NPPB
5 regulation of blood vessel diameter GO:0097746 8.96 ACE NPPB
6 regulation of blood pressure GO:0008217 8.8 ACE NPPA NPPB

Molecular functions related to Mitral Valve Insufficiency according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 phosphotyrosine binding GO:0001784 8.96 HCK PIK3R2
2 hormone activity GO:0005179 8.8 FBN1 NPPA NPPB

Sources for Mitral Valve Insufficiency

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....